SYRE
Spyre Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$99.04
−0.23%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.08x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 0.30x
Liquidity & coverage
- Current ratio
- 27.40x
- Quick ratio
- 27.40x
- Cash ratio
- 26.70x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $1.1B
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026